| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | integrin binding | 8.43e-06 | 175 | 116 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | calcium ion binding | NID2 DCHS2 COMP PNLIPRP2 DSC3 FAT3 ACTN3 ADGRV1 DNAH7 THBS3 THBS4 CDH22 EDEM2 AOC3 NID1 | 2.90e-05 | 749 | 116 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | collagen binding | 1.09e-04 | 81 | 116 | 5 | GO:0005518 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 COMP DSC3 FAT3 ETS1 ITGA8 ADGRV1 ITGA2B ITGAV ELFN2 CCR2 JAK2 BTN2A2 THBS4 CDH22 DLG3 TLN2 PLEK ALOX5 | 9.88e-06 | 1077 | 117 | 19 | GO:0098609 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 DSC3 MYO1E CNTNAP1 ITGA8 ACTN3 ITGA2B ITGAV HNRNPK JAK2 FAP CDH22 SCARB2 CSPG4 DLG3 TLN2 | 9.76e-05 | 976 | 116 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | focal adhesion | 1.46e-04 | 431 | 116 | 10 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 1.82e-04 | 443 | 116 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 2.37e-04 | 22 | 116 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.24e-04 | 59 | 116 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | gamma-secretase complex | 6.30e-04 | 7 | 116 | 2 | GO:0070765 | |
| GeneOntologyCellularComponent | integrin complex | 7.34e-04 | 32 | 116 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.14e-03 | 210 | 116 | 6 | GO:0031256 | |
| Domain | Laminin_G | 7.29e-08 | 58 | 117 | 7 | IPR001791 | |
| Domain | ConA-like_dom | CNTNAP3B COMP FAT3 CNTNAP1 CNTNAP3 ADGRV1 TRIM27 BTN2A2 THBS3 THBS4 CSPG4 | 1.31e-07 | 219 | 117 | 11 | IPR013320 |
| Domain | - | 1.44e-07 | 95 | 117 | 8 | 2.60.120.200 | |
| Domain | COMP | 2.40e-07 | 3 | 117 | 3 | PF11598 | |
| Domain | Thbs/COMP_coiled-coil | 2.40e-07 | 3 | 117 | 3 | IPR024665 | |
| Domain | EGF | CNTNAP3B NID2 COMP FAT3 CNTNAP1 CNTNAP3 TECTA THBS3 THBS4 NID1 | 2.26e-06 | 235 | 117 | 10 | SM00181 |
| Domain | NIDO_dom | 2.37e-06 | 5 | 117 | 3 | IPR003886 | |
| Domain | NIDO | 2.37e-06 | 5 | 117 | 3 | SM00539 | |
| Domain | NIDO | 2.37e-06 | 5 | 117 | 3 | PF06119 | |
| Domain | TSP_3 | 2.37e-06 | 5 | 117 | 3 | PF02412 | |
| Domain | NIDO | 2.37e-06 | 5 | 117 | 3 | PS51220 | |
| Domain | TSP3 | 2.37e-06 | 5 | 117 | 3 | PS51234 | |
| Domain | TSP_CTER | 2.37e-06 | 5 | 117 | 3 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 2.37e-06 | 5 | 117 | 3 | IPR017897 | |
| Domain | TSP_type-3_rpt | 2.37e-06 | 5 | 117 | 3 | IPR028974 | |
| Domain | - | 2.37e-06 | 5 | 117 | 3 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 2.37e-06 | 5 | 117 | 3 | IPR008859 | |
| Domain | TSP_C | 2.37e-06 | 5 | 117 | 3 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 2.37e-06 | 5 | 117 | 3 | IPR003367 | |
| Domain | LAM_G_DOMAIN | 3.77e-06 | 38 | 117 | 5 | PS50025 | |
| Domain | EGF-like_dom | CNTNAP3B NID2 COMP FAT3 CNTNAP1 CNTNAP3 TECTA THBS3 THBS4 NID1 | 3.79e-06 | 249 | 117 | 10 | IPR000742 |
| Domain | Laminin_G_2 | 4.89e-06 | 40 | 117 | 5 | PF02210 | |
| Domain | LamG | 7.91e-06 | 44 | 117 | 5 | SM00282 | |
| Domain | EGF_CA | 1.66e-05 | 86 | 117 | 6 | PF07645 | |
| Domain | EGF_3 | 1.72e-05 | 235 | 117 | 9 | PS50026 | |
| Domain | EGF_Ca-bd_CS | 3.30e-05 | 97 | 117 | 6 | IPR018097 | |
| Domain | EGF_CA | 3.70e-05 | 99 | 117 | 6 | PS01187 | |
| Domain | Integrin_alpha | 3.81e-05 | 11 | 117 | 3 | PF00357 | |
| Domain | EGF_2 | 4.42e-05 | 265 | 117 | 9 | PS01186 | |
| Domain | FIBRINOGEN_C_1 | 4.59e-05 | 32 | 117 | 4 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 4.59e-05 | 32 | 117 | 4 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 4.59e-05 | 32 | 117 | 4 | PS51406 | |
| Domain | G2F | 1.16e-04 | 3 | 117 | 2 | SM00682 | |
| Domain | EGF_CA | 1.19e-04 | 122 | 117 | 6 | SM00179 | |
| Domain | Integrin_alpha_C_CS | 1.26e-04 | 16 | 117 | 3 | IPR018184 | |
| Domain | EGF-like_Ca-bd_dom | 1.30e-04 | 124 | 117 | 6 | IPR001881 | |
| Domain | EGF | 1.42e-04 | 126 | 117 | 6 | PF00008 | |
| Domain | - | 1.53e-04 | 17 | 117 | 3 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 1.53e-04 | 17 | 117 | 3 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 1.53e-04 | 17 | 117 | 3 | PS00484 | |
| Domain | TY | 1.53e-04 | 17 | 117 | 3 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 1.53e-04 | 17 | 117 | 3 | PS51162 | |
| Domain | Thyroglobulin_1 | 1.53e-04 | 17 | 117 | 3 | PF00086 | |
| Domain | Integrin_alpha-2 | 1.83e-04 | 18 | 117 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 1.83e-04 | 18 | 117 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 1.83e-04 | 18 | 117 | 3 | PF08441 | |
| Domain | Integrin_alpha | 1.83e-04 | 18 | 117 | 3 | IPR000413 | |
| Domain | EGF_1 | 2.05e-04 | 255 | 117 | 8 | PS00022 | |
| Domain | Int_alpha | 2.16e-04 | 19 | 117 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 2.16e-04 | 19 | 117 | 3 | IPR013519 | |
| Domain | G2F | 2.32e-04 | 4 | 117 | 2 | PF07474 | |
| Domain | FERM_f0 | 2.32e-04 | 4 | 117 | 2 | PF16511 | |
| Domain | NIDOGEN_G2 | 2.32e-04 | 4 | 117 | 2 | PS50993 | |
| Domain | GFP | 2.32e-04 | 4 | 117 | 2 | IPR009017 | |
| Domain | FERM_f0 | 2.32e-04 | 4 | 117 | 2 | IPR032425 | |
| Domain | G2_nidogen/fibulin_G2F | 2.32e-04 | 4 | 117 | 2 | IPR006605 | |
| Domain | Pept_S9_AS | 2.32e-04 | 4 | 117 | 2 | IPR002471 | |
| Domain | EGF-like_CS | 2.40e-04 | 261 | 117 | 8 | IPR013032 | |
| Domain | FA58C | 2.93e-04 | 21 | 117 | 3 | SM00231 | |
| Domain | FA58C_3 | 2.93e-04 | 21 | 117 | 3 | PS50022 | |
| Domain | FA58C_1 | 2.93e-04 | 21 | 117 | 3 | PS01285 | |
| Domain | FA58C_2 | 2.93e-04 | 21 | 117 | 3 | PS01286 | |
| Domain | FG_GAP | 3.38e-04 | 22 | 117 | 3 | PS51470 | |
| Domain | PRO_ENDOPEP_SER | 3.84e-04 | 5 | 117 | 2 | PS00708 | |
| Domain | FG-GAP | 4.41e-04 | 24 | 117 | 3 | PF01839 | |
| Domain | F5_F8_type_C | 4.41e-04 | 24 | 117 | 3 | PF00754 | |
| Domain | FG-GAP | 4.41e-04 | 24 | 117 | 3 | IPR013517 | |
| Domain | FA58C | 4.41e-04 | 24 | 117 | 3 | IPR000421 | |
| Domain | Integrin_dom | 4.98e-04 | 25 | 117 | 3 | IPR032695 | |
| Domain | FBG | 7.77e-04 | 29 | 117 | 3 | SM00186 | |
| Domain | - | 8.60e-04 | 30 | 117 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 8.60e-04 | 30 | 117 | 3 | IPR014716 | |
| Domain | - | 1.86e-03 | 39 | 117 | 3 | 2.120.10.30 | |
| Domain | GFP-like | 2.06e-03 | 11 | 117 | 2 | IPR023413 | |
| Domain | - | 2.06e-03 | 11 | 117 | 2 | 2.40.155.10 | |
| Domain | Peptidase_S9 | 2.06e-03 | 11 | 117 | 2 | PF00326 | |
| Domain | Peptidase_S9 | 2.06e-03 | 11 | 117 | 2 | IPR001375 | |
| Domain | EGF_dom | 2.46e-03 | 12 | 117 | 2 | IPR024731 | |
| Domain | EGF_3 | 2.46e-03 | 12 | 117 | 2 | PF12947 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.99e-03 | 46 | 117 | 3 | IPR011042 | |
| Domain | Growth_fac_rcpt_ | 3.02e-03 | 156 | 117 | 5 | IPR009030 | |
| Domain | Ldl_recept_b | 3.37e-03 | 14 | 117 | 2 | PF00058 | |
| Domain | LDLRB | 3.37e-03 | 14 | 117 | 2 | PS51120 | |
| Domain | LY | 3.87e-03 | 15 | 117 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.87e-03 | 15 | 117 | 2 | IPR000033 | |
| Domain | Cadherin_CS | 4.91e-03 | 109 | 117 | 4 | IPR020894 | |
| Domain | LH2 | 5.58e-03 | 18 | 117 | 2 | SM00308 | |
| Domain | CADHERIN_1 | 5.58e-03 | 113 | 117 | 4 | PS00232 | |
| Domain | Cadherin | 5.58e-03 | 113 | 117 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 5.75e-03 | 114 | 117 | 4 | PS50268 | |
| Domain | - | 5.75e-03 | 114 | 117 | 4 | 2.60.40.60 | |
| Domain | CA | 5.93e-03 | 115 | 117 | 4 | SM00112 | |
| Domain | Cadherin-like | 6.11e-03 | 116 | 117 | 4 | IPR015919 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.34e-06 | 199 | 86 | 9 | M7253 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.20e-05 | 84 | 86 | 6 | M7098 | |
| Pathway | WP_FOCAL_ADHESION | 2.83e-05 | 199 | 86 | 8 | M39402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 3.13e-05 | 30 | 86 | 4 | M47724 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.89e-04 | 47 | 86 | 4 | MM14925 | |
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 8.72e-09 | 8 | 118 | 4 | 24460873 | |
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 3.81e-08 | 3 | 118 | 3 | 33910854 | |
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 30622267 | ||
| Pubmed | Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis. | 3.79e-07 | 5 | 118 | 3 | 21670148 | |
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 18467703 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | RPN2 CNTNAP1 CNTNAP3 ITGAV MYORG HNRNPK FAP THBS3 GLA MIA2 SCARB2 CSPG4 EDEM2 NID1 UGGT2 CERS1 SLC39A14 | 6.60e-07 | 1201 | 118 | 17 | 35696571 |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 8.10e-06 | 80 | 118 | 5 | 19389623 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CDC42BPG UBR4 ZNF622 STOX1 CPT1B HNRNPK JAK2 THBS4 SAMD9L ARHGEF33 ERRFI1 ALOX5 | 8.14e-06 | 736 | 118 | 12 | 29676528 |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22750443 | ||
| Pubmed | The absence of nidogen 1 does not affect murine basement membrane formation. | 1.14e-05 | 2 | 118 | 2 | 10958695 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22260998 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17177854 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 25290158 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26807827 | ||
| Pubmed | Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture. | 1.14e-05 | 2 | 118 | 2 | 17008882 | |
| Pubmed | Evidence of nidogen-2 compensation for nidogen-1 deficiency in transgenic mice. | 1.14e-05 | 2 | 118 | 2 | 12475645 | |
| Pubmed | Nidogen-1 and nidogen-2 are found in basement membranes during human embryonic development. | 1.14e-05 | 2 | 118 | 2 | 12005023 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11137453 | ||
| Pubmed | COMP and TSP-4 interact specifically with the novel GXKGHR motif only found in fibrillar collagens. | 1.14e-05 | 2 | 118 | 2 | 30464261 | |
| Pubmed | ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. | 1.14e-05 | 2 | 118 | 2 | 26198048 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 31150793 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22623588 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17616934 | ||
| Pubmed | Hematopoietic cells are a source of nidogen-1 and nidogen-2 during mouse liver development. | 1.14e-05 | 2 | 118 | 2 | 16618944 | |
| Pubmed | Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. | 1.14e-05 | 2 | 118 | 2 | 17328794 | |
| Pubmed | 2.06e-05 | 16 | 118 | 3 | 15878328 | ||
| Pubmed | 2.14e-05 | 164 | 118 | 6 | 32409323 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | MYO1E RPN2 UBR4 CNTNAP1 GABARAPL2 MCOLN1 HNRNPK CCR2 APH1A CERS1 SLC39A14 | 2.66e-05 | 697 | 118 | 11 | 28298427 |
| Pubmed | 2.98e-05 | 174 | 118 | 6 | 32149426 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 33727640 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 23681936 | ||
| Pubmed | Critical role of the WASF3 gene in JAK2/STAT3 regulation of cancer cell motility. | 3.42e-05 | 3 | 118 | 2 | 23677069 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 33068727 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 19888429 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 12031826 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 29063123 | ||
| Pubmed | [Expression and significance of integrins subunits in laryngeal squamous cell carcinoma]. | 3.42e-05 | 3 | 118 | 2 | 20942236 | |
| Pubmed | Presenilin 1 and Presenilin 2 Target γ-Secretase Complexes to Distinct Cellular Compartments. | 3.42e-05 | 3 | 118 | 2 | 27059953 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 10891446 | ||
| Pubmed | EXOSC10 PSEN2 OFD1 RPN2 UBR4 ADCY3 HNRNPK MIA2 APH1A PREP SCARB2 PLEK YME1L1 CTSW | 4.36e-05 | 1168 | 118 | 14 | 19946888 | |
| Pubmed | 5.60e-05 | 285 | 118 | 7 | 21423176 | ||
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 6.42e-05 | 23 | 118 | 3 | 23152823 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 20033473 | ||
| Pubmed | CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. | 6.82e-05 | 4 | 118 | 2 | 16888027 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 23533276 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 9670957 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 6.82e-05 | 4 | 118 | 2 | 6338048 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 22308022 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 27216177 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 9118959 | ||
| Pubmed | Expression profiles of two human APH-1 genes and their roles in formation of presenilin complexes. | 6.82e-05 | 4 | 118 | 2 | 15629423 | |
| Pubmed | Structure and chromosomal localization of mouse G protein subunit gamma 4 gene. | 6.82e-05 | 4 | 118 | 2 | 9570961 | |
| Pubmed | Adhesion of cultured human kidney mesangial cells to native entactin: role of integrin receptors. | 6.82e-05 | 4 | 118 | 2 | 9686320 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 20158572 | ||
| Pubmed | Morphofunctional studies of the glomerular wall in mice lacking entactin-1. | 6.82e-05 | 4 | 118 | 2 | 14566019 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | NID2 CPNE9 COMP WASF3 ACTN3 ITGAV HNRNPK CILP2 THBS4 GLA SCARB2 CSPG4 NID1 | 7.25e-05 | 1070 | 118 | 13 | 23533145 |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.05e-04 | 27 | 118 | 3 | 31541017 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 21597003 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 23271751 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 12471034 | ||
| Pubmed | Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. | 1.13e-04 | 5 | 118 | 2 | 15322084 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 21646718 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 19805288 | ||
| Pubmed | Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic intervention. | 1.13e-04 | 5 | 118 | 2 | 29617956 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 12243745 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 11493006 | ||
| Pubmed | Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology. | 1.13e-04 | 5 | 118 | 2 | 31999726 | |
| Pubmed | Increased expression of PS1 is sufficient to elevate the level and activity of γ-secretase in vivo. | 1.13e-04 | 5 | 118 | 2 | 22140537 | |
| Pubmed | An alternative spliced mouse presenilin-2 mRNA encodes a novel gamma-secretase inhibitor. | 1.13e-04 | 5 | 118 | 2 | 19376115 | |
| Pubmed | Basic amino-acid side chains regulate transmembrane integrin signalling. | 1.13e-04 | 5 | 118 | 2 | 22178926 | |
| Pubmed | Identification of proteins interacting with the rat somatostatin receptor subtype 2. | 1.13e-04 | 5 | 118 | 2 | 11087996 | |
| Pubmed | Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD-95. | 1.13e-04 | 5 | 118 | 2 | 15255944 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 11733994 | ||
| Pubmed | The basement membrane of hair follicle stem cells is a muscle cell niche. | 1.17e-04 | 28 | 118 | 3 | 21335239 | |
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 1.60e-04 | 31 | 118 | 3 | 31550482 | |
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 11802788 | ||
| Pubmed | Integrins take partners: cross-talk between integrins and other membrane receptors. | 1.70e-04 | 6 | 118 | 2 | 9789327 | |
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 11956183 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 12297508 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.70e-04 | 6 | 118 | 2 | 34143959 | |
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 20130175 | ||
| Pubmed | Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins. | 1.70e-04 | 6 | 118 | 2 | 10544250 | |
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 15474363 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 22074918 | ||
| Pubmed | Nidogen-2: a new basement membrane protein with diverse binding properties. | 1.70e-04 | 6 | 118 | 2 | 9733643 | |
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 27608597 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 23789102 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 9219695 | ||
| Pubmed | Comparative analysis of human 19p12-13 region in Fugu and mouse. | 2.37e-04 | 7 | 118 | 2 | 11353399 | |
| Pubmed | Integrins are required for the differentiation of visceral endoderm. | 2.37e-04 | 7 | 118 | 2 | 19118216 | |
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 16059920 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 12042322 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 15162516 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 10048576 | ||
| Pubmed | Impaired αVβ8 and TGFβ signaling lead to microglial dysmaturation and neuromotor dysfunction. | 2.37e-04 | 7 | 118 | 2 | 30846482 | |
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 16641999 | ||
| Pubmed | The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. | 2.37e-04 | 7 | 118 | 2 | 37184585 | |
| Pubmed | 2.52e-04 | 613 | 118 | 9 | 22268729 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 27349870 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 12015298 | ||
| Interaction | BTNL2 interactions | CNTNAP3B CNTNAP1 CNTNAP3 ITGAV MYORG CILP2 CSPG4 EDEM2 UGGT2 | 3.04e-07 | 155 | 117 | 9 | int:BTNL2 |
| Interaction | FBXO2 interactions | CNTNAP3B NID2 CNTNAP1 CNTNAP3 ITGA8 ADGRV1 ITGAV MYORG CILP2 CSPG4 EDEM2 NID1 | 4.91e-06 | 411 | 117 | 12 | int:FBXO2 |
| Interaction | CD160 interactions | 8.49e-06 | 48 | 117 | 5 | int:CD160 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 5.35e-05 | 18 | 75 | 3 | 1160 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.05e-04 | 181 | 75 | 6 | 694 | |
| Coexpression | DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS | 1.80e-06 | 45 | 118 | 5 | M40098 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.82e-07 | 176 | 119 | 7 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.01e-07 | 177 | 119 | 7 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 187 | 119 | 7 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 187 | 119 | 7 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 187 | 119 | 7 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-07 | 194 | 119 | 7 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-07 | 194 | 119 | 7 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-07 | 194 | 119 | 7 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 199 | 119 | 7 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-06 | 142 | 119 | 6 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.40e-06 | 143 | 119 | 6 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-06 | 149 | 119 | 6 | c9334f319a0c943268e54b6f0c9446736172c3a9 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-06 | 157 | 119 | 6 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-06 | 157 | 119 | 6 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.11e-06 | 157 | 119 | 6 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 159 | 119 | 6 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.28e-06 | 164 | 119 | 6 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 167 | 119 | 6 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 167 | 119 | 6 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-06 | 167 | 119 | 6 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-06 | 168 | 119 | 6 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Basophil|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-06 | 170 | 119 | 6 | bca78719c17355772ad6c53ee75e459faf1d089f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-06 | 170 | 119 | 6 | 40d863554ec98ae43f76511c1112859688846613 | |
| ToppCell | ASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.49e-06 | 170 | 119 | 6 | 84705434234bf2fbb5256bd5a1f6ab54c01c5a51 | |
| ToppCell | ASK454-Immune-NK_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.94e-06 | 172 | 119 | 6 | c9e738c3540ee09b08805b1cdb66b4a0d9d40d33 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-06 | 173 | 119 | 6 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 7.18e-06 | 173 | 119 | 6 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-06 | 173 | 119 | 6 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.92e-06 | 176 | 119 | 6 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 178 | 119 | 6 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 178 | 119 | 6 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 178 | 119 | 6 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 8.72e-06 | 179 | 119 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.72e-06 | 179 | 119 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.72e-06 | 179 | 119 | 6 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.00e-06 | 180 | 119 | 6 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.59e-06 | 182 | 119 | 6 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.59e-06 | 182 | 119 | 6 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.02e-05 | 184 | 119 | 6 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.08e-05 | 186 | 119 | 6 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-05 | 188 | 119 | 6 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 188 | 119 | 6 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-05 | 188 | 119 | 6 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-05 | 189 | 119 | 6 | cfa45fa6b13fcd3f54c29c823885f5b938812474 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 189 | 119 | 6 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.22e-05 | 190 | 119 | 6 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.30e-05 | 192 | 119 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 119 | 6 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.38e-05 | 194 | 119 | 6 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-05 | 194 | 119 | 6 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 1.38e-05 | 194 | 119 | 6 | 749dd8113ef260e00facac09de9861d61725124a | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.42e-05 | 195 | 119 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 195 | 119 | 6 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 195 | 119 | 6 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.42e-05 | 195 | 119 | 6 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 196 | 119 | 6 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-05 | 196 | 119 | 6 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.50e-05 | 197 | 119 | 6 | 598fb7a9a8400af49d90807b3155d3cc1c34f505 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-05 | 197 | 119 | 6 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-05 | 198 | 119 | 6 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 198 | 119 | 6 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 198 | 119 | 6 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 198 | 119 | 6 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-05 | 198 | 119 | 6 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 198 | 119 | 6 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.55e-05 | 198 | 119 | 6 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 198 | 119 | 6 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-05 | 198 | 119 | 6 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 198 | 119 | 6 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.59e-05 | 199 | 119 | 6 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-05 | 199 | 119 | 6 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.59e-05 | 199 | 119 | 6 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.59e-05 | 199 | 119 | 6 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 199 | 119 | 6 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-05 | 199 | 119 | 6 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-05 | 199 | 119 | 6 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 199 | 119 | 6 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Car3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.02e-05 | 134 | 119 | 5 | 4ef5f395e321cf04e56560be2502a8aa157682f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-05 | 148 | 119 | 5 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-05 | 148 | 119 | 5 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-05 | 148 | 119 | 5 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-05 | 152 | 119 | 5 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-05 | 152 | 119 | 5 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | facs-Heart-RV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 153 | 119 | 5 | af0ae08ff35f8210268457e5e15bcbe5d1f46d67 | |
| ToppCell | facs-Heart-RV-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 153 | 119 | 5 | 984a2d847f4376183fdbab7ebc77c1bf7d448f44 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.87e-05 | 154 | 119 | 5 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | Control-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 6.06e-05 | 155 | 119 | 5 | 4b9369b203a4d7071c56d3d8e6b450e9a0121c41 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-05 | 156 | 119 | 5 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_P4HA3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-05 | 157 | 119 | 5 | 13f045df0cde2f7736b6ed3906beb06d694e2432 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.63e-05 | 158 | 119 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.83e-05 | 159 | 119 | 5 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 7.04e-05 | 160 | 119 | 5 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.04e-05 | 160 | 119 | 5 | 5d22c86deead516444349d495998e04586be4396 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Mast|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.04e-05 | 160 | 119 | 5 | ca212634cf1875238071d1800ecdf34979a553fb | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.04e-05 | 160 | 119 | 5 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | Influenza_Severe-gd_T|World / Disease group and Cell class | 7.25e-05 | 161 | 119 | 5 | b3cdaed4d58d57e3c5dbc904a09388f3bf949407 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.35e-06 | 8 | 117 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | total sitosterol measurement | 4.66e-05 | 3 | 117 | 2 | EFO_0020965 | |
| Disease | cortical surface area measurement | TRPM6 DCHS2 CPAMD8 FAT3 ETS1 ADGRV1 STOX1 DNAH7 STRIP1 SNX13 TG PDGFD EDEM2 RASGEF1C NT5C2 TLN2 | 8.33e-05 | 1345 | 117 | 16 | EFO_0010736 |
| Disease | nidogen-2 measurement | 9.30e-05 | 4 | 117 | 2 | EFO_0020608 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.30e-04 | 75 | 117 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 4.30e-04 | 8 | 117 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | sarcoma (is_implicated_in) | 4.30e-04 | 8 | 117 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 8.38e-04 | 11 | 117 | 2 | EFO_0801461 | |
| Disease | celiac disease | 1.62e-03 | 126 | 117 | 4 | EFO_0001060 | |
| Disease | Cerebrovascular accident | 1.94e-03 | 62 | 117 | 3 | C0038454 | |
| Disease | ulcerative colitis | 2.23e-03 | 335 | 117 | 6 | EFO_0000729 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 2.29e-03 | 18 | 117 | 2 | C0751779 | |
| Disease | venous thromboembolism, fibrinogen measurement | 2.42e-03 | 67 | 117 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | portal hypertension (implicated_via_orthology) | 2.55e-03 | 19 | 117 | 2 | DOID:10762 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis, ulcerative colitis | 3.12e-03 | 21 | 117 | 2 | EFO_0000685, EFO_0000729 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.20e-03 | 152 | 117 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | breast cancer, COVID-19 | 3.42e-03 | 22 | 117 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.73e-03 | 23 | 117 | 2 | C1335177 | |
| Disease | Liver Cirrhosis, Experimental | 3.75e-03 | 774 | 117 | 9 | C0023893 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PEGSYFSKYSEAAEL | 676 | Q9Y2D5 | |
| YDGPFCSNEISAYFA | 991 | Q9BZ76 | |
| YFDGDDAISYRFPRG | 176 | P78357 | |
| AYGHYEAFSTLAPEA | 391 | Q6UVK1 | |
| GYPQELLSFAYDSTF | 81 | P49902 | |
| PLYASYKADSFSEGD | 466 | Q9BUH8 | |
| GAPFYTTYRTADGEF | 216 | Q9UHK6 | |
| VTDDDYAGFIFGYQD | 591 | P49747 | |
| YGEDAGDFFDTYAAA | 71 | Q8WXG9 | |
| AAYEEFEYGGEIFAL | 611 | A8MVX0 | |
| DYFDANPYFSEESLP | 201 | A7E2U8 | |
| FSGYLVYADADADAP | 151 | Q9BXJ3 | |
| ELEDGLYTTGPYFFA | 481 | Q9H221 | |
| YYDSTTPGFEDDSGE | 471 | Q5JTC6 | |
| SGDALYEFYEPDDSL | 501 | Q5JTC6 | |
| PGSFGYYDIDAQTFA | 146 | P06280 | |
| FGLSSSLDYPDFYGD | 176 | Q16581 | |
| DLRYGGDYDSFADVV | 46 | Q2TB18 | |
| RPYNFFDEDPSFYSA | 706 | Q16853 | |
| FDEDPSFYSADSIYF | 711 | Q16853 | |
| SFYSADSIYFRGDQD | 716 | Q16853 | |
| SLFTADTYDTDGYNP | 421 | Q5T8P6 | |
| EADYLTFPSGEYVAE | 51 | O60674 | |
| GYEYSLSVFFPESGL | 86 | O75665 | |
| AYELLFGETPFYAES | 266 | Q6DT37 | |
| FGETPFYAESLVETY | 271 | Q6DT37 | |
| LLGYSDGADDTFAAY | 106 | Q9GZU1 | |
| YAYSDNSLDPGLFVE | 71 | Q9UH92 | |
| PASGDFDFYELILYN | 1196 | P23467 | |
| IFATGYSFAYPFLDE | 326 | P31513 | |
| GDSPYYFLTSAFLTA | 151 | Q96BI3 | |
| AYDSYLENAFPFDEL | 46 | Q9BV94 | |
| PSYDSFDSEDYPAAL | 281 | P14921 | |
| YYSLLEDFQPAAASE | 166 | Q9GZP0 | |
| GDDENPSAYYSDILF | 51 | Q9HCI6 | |
| SDSSSYAIFLYPEDG | 186 | P14543 | |
| DDAYYFYGSRNTFDP | 551 | Q1MSJ5 | |
| LESDSAFIGAYGETY | 1096 | Q1MSJ5 | |
| SIGYEGSYDASADLF | 666 | Q8IXT1 | |
| SLEYYGIEADDNPFF | 96 | Q9UII6 | |
| DPLVAEEYYADAFDS | 471 | Q8NG66 | |
| FASEYYLESEGQPLS | 1371 | Q8NG31 | |
| GPDEESFLYFAYGSN | 11 | O75223 | |
| EVAPASYDDSYLGYS | 256 | P53708 | |
| DEFPGMFTYDYDTAL | 816 | Q68CR7 | |
| TASDADSGLYGFIEY | 686 | Q6V1P9 | |
| SLYDGFLSYEAPQAF | 701 | Q6V1P9 | |
| DYLANASDFPDYAAA | 6 | Q96P68 | |
| LASDGSDSYALFLYP | 186 | Q14112 | |
| ALRGYAFSEDGEYFA | 126 | P48147 | |
| AFSEDGEYFAYGLSA | 131 | P48147 | |
| NRDAGYFFSTASEYP | 131 | Q7Z6W7 | |
| TPYDYSQSDFKAFAG | 816 | Q01780 | |
| YDVFDLIAYASTADG | 206 | Q14574 | |
| VSTAFVADSEGDFYY | 246 | Q8N5D6 | |
| NATYFDYAASLPEDD | 176 | O75460 | |
| FAGEFYDLRYLSEEG | 66 | Q9P0K9 | |
| EAEGVPRAYTYSAFF | 931 | Q8IZJ3 | |
| IFDDSYLGYSVAVGD | 246 | P06756 | |
| IQDYDSDKLFPAYGF | 341 | Q8IYJ1 | |
| LGDSTIEYAPDFRFY | 3066 | Q8WXX0 | |
| YSLYGSGNSEFFLDP | 3066 | Q8TDW7 | |
| FSDLTEEEFGQLYGY | 91 | P56202 | |
| GFSEPEYSAEYSAEY | 6 | O60266 | |
| SGEEVTTFFDYDYGA | 16 | P41597 | |
| SAYLLFGTDYPFFHD | 116 | P27544 | |
| YAPPDYASTFTALAD | 321 | Q92796 | |
| EADFLFAYSTVPGYY | 216 | P55210 | |
| ETPSFGVYFLTYDAL | 161 | Q8N8R3 | |
| EDFENGTAYARYGSF | 336 | Q8N539 | |
| PYDAFQTYAFEGADS | 766 | Q9UJ99 | |
| EDEAGELYFLATSYP | 571 | Q6UWX4 | |
| GEEYDFSVDYFALGV | 366 | Q15835 | |
| VGVFLDYEAGDVSFY | 446 | Q8WVV5 | |
| SVVAFPLEDFYLGTY | 126 | A6NIM6 | |
| FGFNPLEDYYVSKSA | 211 | Q15043 | |
| YDGPFCSNEISAYFA | 991 | Q96NU0 | |
| AFFVALDEESYSYDP | 416 | Q92523 | |
| EDGFLYVAYSGENTF | 101 | P60520 | |
| FEYYSSSVLNPDGFL | 286 | P54317 | |
| PFDELLALYGYEASD | 86 | Q8N344 | |
| IEPGFYATYESTLFE | 161 | Q96PC5 | |
| CFNYDADDYPAGSSD | 11 | A0A1W2PRP0 | |
| LETFAYQEGSYDSLP | 196 | Q96C34 | |
| GAATYLPDFLDYFSF | 406 | Q6PCB5 | |
| SDTVYADYDPYAVAG | 566 | Q9Y5W8 | |
| VGIFLDYDAGEVSFY | 436 | P14373 | |
| SYYSFTGFKDPDEDL | 166 | Q8N3R3 | |
| PFYNDFERGAVDSYD | 41 | P09917 | |
| SFYLGFSIEGPLAYD | 1566 | Q8IVG5 | |
| DNPDAFYYFPDSGFF | 211 | P08567 | |
| DPNFYDETYDYGGFT | 226 | P61978 | |
| TFATYGYALDPSLDN | 131 | O60508 | |
| GYSESPDLEFEYADT | 61 | Q5VSL9 | |
| FEFYEGPFEYNSTRC | 46 | O15466 | |
| GDYVFLTGEDSYLNF | 211 | Q14108 | |
| SLSFDSSNPEYFDGY | 251 | P08514 | |
| YFDTPAVSAADLSYV | 211 | Q9UJM3 | |
| FRHYTVGSYDSFDAP | 631 | Q9Y566 | |
| SPVYEYTTEAADFGL | 56 | Q8IVF2 | |
| LDYVAFSSALYGESD | 886 | Q08043 | |
| DGDFESLAAIRFYYG | 71 | Q8IUL8 | |
| YDVDDPFSVEEGFSY | 696 | Q8TBB6 | |
| DSLFYSSNEFEEYPG | 406 | Q12884 | |
| GASYAFPSEFSYTLL | 726 | O75443 | |
| TDDDYAGFIFGYQDS | 791 | P35443 | |
| SVFGSLRDSGYFYDP | 411 | Q86UC2 | |
| KYGPEFADAYSSLAS | 576 | Q8IUR5 | |
| SDDPESTGFLYPYND | 596 | Q9BX84 | |
| FSSGYYDFLVEVEGD | 341 | P04844 | |
| ASAPADERIFDYYSA | 846 | Q6ZVD7 | |
| YTAPIFSEDGLYLAS | 426 | Q8N431 | |
| DGLKFYTDPSYFFDL | 146 | Q9UPY6 | |
| YEESYGEALEGFSRA | 236 | Q8N0Z6 | |
| DSYDSFGEPSYPEVF | 326 | P49810 | |
| FNFSYGDYDLPMDED | 26 | Q8NFJ6 | |
| VTDDDYAGFLFSYQD | 786 | P49746 | |
| ADVPFYYASGSEFDE | 396 | Q96TA2 | |
| PKSFTLDFGEYQESY | 366 | Q9Y4G6 | |
| LEFADFYDFRSSYPD | 341 | Q969S3 | |
| DGYSSLAYVPEFFAD | 616 | Q14139 | |
| GPLDEDFYAEDFYLL | 881 | Q9NYU1 | |
| FYPLIGREAEYFFDS | 1266 | Q5TAX3 | |
| VESAFEVDGPYYFTV | 5026 | Q5T4S7 | |
| FYPAYEGQFSLEEKS | 2636 | P01266 | |
| YGFVEFLSEEDADYA | 56 | Q15427 | |
| SFPALYYEEGADSLS | 711 | Q5R3F8 | |
| YAAVESEEFLAFPAY | 296 | Q12965 | |
| YTPAYGDFDFDEVKF | 356 | Q6NSJ0 |